Pancreatic Cancer Research

ResearcherGuilin Medical UniversityActive in the last 2 years

Lin Ye

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0303-2409; OpenAlex author ID A5100780504. Sources: OpenAlex.

Their work

Papers
11 (first author 3, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
21
Papers, trials and grants by year

2016: 1 paper · 2017: 1 paper · 2018: none · 2019: none · 2020: 2 papers · 2021: 4 papers · 2022: none · 2023: 1 paper · 2024: 2 papers

Papers 11

  1. Pancreatic cancer-derived exosomal miR-510 promotes macrophage M2 polarization and facilitates cancer cell aggressive phenotypes. First author DOI 10.1007/s13577-024-01144-0↗
  2. Implication of Capillary Morphogenesis Gene 2 (CMG2) in the Disease Progression and Peritoneal Metastasis of Pancreatic Cancer. Last author DOI 10.3390/cancers16162893↗
  3. miR-4299 inhibits tumor progression in pancreatic cancer through targeting ADAM17. First author DOI 10.1007/s11010-022-04617-8↗
  4. Panax notoginseng Saponins Promote Cell Death and Chemosensitivity in Pancreatic Cancer through the Apoptosis and Autophagy Pathways. Co-author DOI 10.2174/1871520620999201110191459↗
  5. Expression of Death Associated Proteins DAP1 and DAP3 in Human Pancreatic Cancer. First author DOI 10.21873/anticanres.15010↗
  6. Reduced kinase D‑interacting substrate of 220 kDa (Kidins220) in pancreatic cancer promotes EGFR/ERK signalling and disease progression. Last author DOI 10.3892/ijo.2021.5214↗
  7. Four potential microRNAs affect the progression of pancreatic ductal adenocarcinoma by targeting MET via the PI3K/AKT signaling pathway. Co-author DOI 10.3892/ol.2021.12588↗
  8. Circulating exosomal microRNAs as novel detection biomarkers in pancreatic cancer Co-author DOI 10.21203/rs.2.22716/v1↗
  9. Circulating exosomal microRNAs as novel potential detection biomarkers in pancreatic cancer. Co-author DOI 10.3892/ol.2020.11691↗
  10. Psoriasin promotes invasion, aggregation and survival of pancreatic cancer cells; association with disease progression. Last author DOI 10.3892/ijo.2017.3953↗
  11. IL24 and its Receptors Regulate Growth and Migration of Pancreatic Cancer Cells and Are Potential Biomarkers for IL24 Molecular Therapy. Co-author PMID 26977011↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chunyi Hao · 5 shared papers, 2016–2024 · strength 0.57
  2. Wen G. Jiang · 5 shared papers, 2016–2024 · strength 0.57
  3. Lun Wu · 4 shared papers, 2020–2021 · strength 0.48
  4. Yaqun Yu · 2 shared papers, 2023–2024 · strength 0.39
  5. Tao Wang · 2 shared papers, 2023–2024 · strength 0.39
  6. Bilal A. Al-Sarireh · 3 shared papers, 2017–2024 · strength 0.36
  7. Laijian Sui · 2 shared papers, 2021–2024 · strength 0.34
  8. Lichao Yao · 2 shared papers, 2021 · strength 0.28
  9. Lulu Zhai · 2 shared papers, 2021 · strength 0.28
  10. Zhi‐Gang Tang · 2 shared papers, 2020–2021 · strength 0.25
  11. Ziqian Fang · 1 shared paper, 2024 · strength 0.19
  12. Jiafu Ji · 2 shared papers, 2016–2021 · strength 0.18
  13. Junhong Liu · 1 shared paper, 2023 · strength 0.17
  14. Shuo Cai · 2 shared papers, 2017–2021 · strength 0.17
  15. Yiming Yang · 1 shared paper, 2021 · strength 0.15
  16. Zhi‐Gang Tang · 1 shared paper, 2021 · strength 0.13
  17. Zhigang Tang · 1 shared paper, 2020 · strength 0.10
  18. Hongmei Wang · 1 shared paper, 2020 · strength 0.10
  19. Yongning Jia · 1 shared paper, 2016 · strength 0.07
  20. Gang Chen · 1 shared paper, 2017 · strength 0.06
  21. Ying Liu · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.